Relative Bioavailability Study of 4 Different Formulations of PF-07321332 Relative to the Commercial Tablet Formulation

Clinical trial NCT05263895 · COMPLETED

Trial details

NCT number: NCT05263895
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bioavailability

Start date: 2022-03-03
Primary completion: 2022-05-16
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.